The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway

Ruixin Liu, Dingxie Liu, Eliana Trink, Ermal Bojdani, Guang Ning, Mingzhao Xing

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds